|
|
|
|
| LEADER |
01723nam a2200205Ia 4500 |
| 001 |
10-3390-ijms23084298 |
| 008 |
220425s2022 CNT 000 0 und d |
| 020 |
|
|
|a 16616596 (ISSN)
|
| 245 |
1 |
0 |
|a Activity of Silver Nanoparticles against Staphylococcus spp.
|
| 260 |
|
0 |
|b MDPI
|c 2022
|
| 856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.3390/ijms23084298
|
| 520 |
3 |
|
|a Staphylococcus epidermidis is a bacterium that is part of the human microbiota. It is most abundant on the skin, in the respiratory system and in the human digestive tract. Also, Staphylococcus aureus contributes to human infections and has a high mortality rate. Both of these bacterial species produce biofilm, a pathogenic factor increasing their resistance to antibiotics. For this reason, we are looking for new substances that can neutralize bacterial cells. One of the best-known substances with such effects are silver nanoparticles. They exhibited antibacterial and antibiofilm formation activity that depended on their size, shape and the concentration used. In this review, we presented the data related to the use of silver nanoparticles in counteracting bacterial growth and biofilm formation published in scientific papers between 2017 and 2021. Based on the review of experimental results, the properties of nanoparticles prompt the expansion of research on their activity. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.
|
| 650 |
0 |
4 |
|a antibiofilm activity
|
| 650 |
0 |
4 |
|a antimicrobial activity
|
| 650 |
0 |
4 |
|a silver nanoparticles
|
| 650 |
0 |
4 |
|a Staphylococcus aureus
|
| 650 |
0 |
4 |
|a Staphylococcus epidermidis
|
| 700 |
1 |
|
|a Swolana, D.
|e author
|
| 700 |
1 |
|
|a Wojtyczka, R.D.
|e author
|
| 773 |
|
|
|t International Journal of Molecular Sciences
|
